VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ENVB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ENVBEnveric Biosciences, Inc.
$1.45$865667
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksENVBQuarterly Financials

Enveric Biosciences, Inc. (ENVB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Enveric Biosciences, Inc. (ENVB) quarterly income statement — complete revenue, gross profit & net income history

ENVB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %-----------------100%-100%-100%
Cost of Goods Sold37.24K39.48K40.37K39.98K81.02K82.49K84.81K84.78K85.41K84.68K95.84K114.37K113.33K90.42K121.1K85.5K103.72K197.26K173.7K174.02K
COGS % of Revenue--------------------
Gross Profit-37.24K-39.48K-40.37K-39.98K-81.02K-82.49K-84.81K-84.78K-85.41K-84.68K-95.84K-114.37K-113.33K-90.42K-121.1K-85.5K-103.72K-197.26K-173.7K-174.02K
Gross Margin %--------------------
Gross Profit Growth %54.04%52.13%52.4%52.84%5.13%2.59%11.5%25.88%24.64%6.35%20.86%-33.77%-9.27%54.16%30.28%50.87%24.09%99.73%-109.2%-109.57%
Operating Expenses1.6M2.15M1.83M2.48M2.11M3.09M2M1.81M2.39M2.3M3.35M5.64M4.75M4.71M5.54M4.62M4.69M12.1M3.34M3.19M
OpEx % of Revenue--------------------
Selling, General & Admin1.25M1.78M1.43M1.22M1.36M1.99M1.24M1.3M1.93M930.68K2M3.13M2.76M2.82M3.48M2.5M2.73M9.61M2.12M2.31M
SG&A % of Revenue--------------------
Research & Development345.97K372.18K402.42K1.26M746.37K1.1M762.72K515.5K458.15K1.37M1.35M2.51M1.99M1.89M2.06M2.12M1.96M2.49M1.22M879.84K
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-1.63M-2.19M-1.87M-2.52M-2.19M-3.17M-2.08M-1.9M-2.48M-2.38M-3.45M-5.76M-4.86M-4.8M-5.66M-4.71M-4.8M-12.3M-3.52M-3.36M
Operating Margin %--------------------
Operating Income Growth %25.34%30.87%10.04%-32.73%11.7%-33.11%39.59%67.02%49.03%50.35%39.04%-22.27%-1.35%60.96%-60.85%-39.96%29.11%-619.47%-214.36%-183.45%
EBITDA-1.6M-2.15M-1.83M-2.48M-2.11M-3.09M-2M-1.81M-2.39M-2.3M-3.35M-5.64M-4.75M-4.71M-5.54M-4.62M-4.69M-12.1M-3.34M-3.19M
EBITDA Margin %--------------------
EBITDA Growth %24.24%30.31%8.25%-36.73%11.93%-34.42%40.39%67.86%49.62%51.19%39.44%-22.06%-1.18%61.07%-65.58%-44.91%29.21%-273.71%-494.42%-388.66%
D&A (Non-Cash Add-back)37.24K39.48K40.37K39.98K81.02K82.49K84.81K84.78K85.41K84.68K95.84K114.37K113.33K90.42K121.1K85.5K103.72K197.26K173.7K174.02K
EBIT-1.63M-2.19M-1.87M-2.52M-2.18M-3.15M-2.08M-1.88M-2.48M-3.41M-2.82M-6.36M-4.68M-10.16M-2.48M-2.79M-4.52M-49.56M-2.71M-903.47K
Net Interest Income-303-250274-1320-2250-356965662.24K916-11-135-308-668-4.14K-5.13K-370-4.82K
Interest Income0027400-225006965662.24K91600000000
Interest Expense303250013200035-000111353086684.14K5.13K3704.82K
Other Income/Expense-303-248274-1322.57K26.38K-84018.54K22.13K-1.03M632.77K-601.05K183.15K-5.36M3.18M1.92M271.83K-37.26M804.46K2.45M
Pretax Income-1.63M-2.19M-1.87M-2.52M-2.18M-3.15M-2.08M-1.88M-2.46M-3.41M-2.82M-6.36M-4.68M-10.16M-2.48M-2.79M-4.52M-49.56M-2.71M-908.29K
Pretax Margin %--------------------
Income Tax000007.2K001.73K22.32K6.59K00-1.49M000-7.45M00
Effective Tax Rate %0%0%0%0%0%-0.23%0%0%-0.07%-0.65%-0.23%0%0%14.62%0%0%0%15.04%0%0%
Net Income-1.63M-2.19M-1.87M-2.52M-2.18M-3.15M-2.08M-1.88M-2.46M-3.44M-2.82M-6.36M-4.69M-8.69M-2.49M-2.8M-4.52M-42.11M-2.71M-908.29K
Net Margin %--------------------
Net Income Growth %25.24%30.45%10.09%-34.04%11.07%8.19%26.16%70.46%47.61%60.46%-13.27%-127.38%-3.67%79.36%8.14%-208.09%-39.17%-1554.08%-182.2%42.27%
Net Income (Continuing)-1.63M-2.19M-1.87M-2.52M-2.18M-3.15M-2.08M-1.88M-2.46M-3.44M-2.82M-6.36M-4.68M-8.68M-2.48M-2.79M-4.52M-42.11M-2.71M-908.29K
Discontinued Operations00000000000000000000
Minority Interest0000000000001.01M885.03K761.43K637.84K0000
EPS (Diluted)-1.08-3.81-10.81-11.64-14584.44-57.84-17.76-16.08-21.00-33.51-27.53-62.42-46.82-85.844.56-10.08-60.12-1091.64-70.92-25.56
EPS Growth %99.99%93.41%39.13%27.61%-69349.71%-72.61%35.49%74.24%55.15%60.96%-703.73%-519.25%22.12%92.14%106.43%60.56%50%-315.01%27.93%84.64%
EPS (Basic)-1.08-3.81-10.81-11.64-14584.44-69.84-43.08-9.84-7.32-17.52-15.60-36.24-26.64-81.123.24-10.08-60.12-1091.64-70.92-25.56
Diluted Shares Outstanding1.51M1.06M313.24K216.31K15054.58K117.25K117.25K117.25K102.53K102.53K102.53K102.53K102.53K102.53K87.81K70.59K38.57K38.27K35.57K
Basic Shares Outstanding1.51M1.06M313.24K216.31K15041.91K48.35K190.9K333.45K149.22K149.22K149.22K149.22K149.22K149.22K87.81K70.59K38.57K38.27K35.56K
Dividend Payout Ratio--------------------